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ABSTRACT  
Contraception may provide a useful nonlethal management tool when it is desirable to reduce 
populations of birds. We tested the efficacy of 20,25 diazacholesterol, and immunization with 
avian gonadotropin-releasing hormone (AGnRH-I) and chicken riboflavin carrier protein (cRCP) 
as contraceptives and investigated their modes of action in Coturnix quail (Coturnix coturnix 
japonica). Females that were paired with males treated with 20,25 diazacholesterol produced 
lower percentages of eggs that were fertile and hatched. Females treated with 20,25 
diazacholesterol and paired with control males laid fewer eggs, and lower percentages of their 
eggs were fertile and hatched. Treatment with 20,25 diazacholesterol reduced testosterone 
levels in males and progesterone levels in females. Nonesterified cholesterol levels were 
reduced, whereas desmosterol levels increased in birds treated with 20,25 diazacholesterol. 
Treatment with AGnRH-I and cRCP immunocontraceptive vaccines did not decrease average 
egg production and hatchability or hormone levels, but this failure might have been due to the 
vaccination protocol. If registered, wildlife managers may be able to use 20,25 diazacholesterol 
when other methods, such as lethal control, are undesirable for reducing damage caused by 
specific breeding behaviors such as the building of nests. 
(Key Words: avian gonadotropin-releasing hormone, chicken riboflavin carrier protein, 20,25 
diazacholesterol, immunocontraception, reproductive inhibition) 
2004 Poultry Science 83:234-244  
 
Effectiveness of Twenty, Twenty-Five Diazacholesterol, Avian Gonadotropin- 
Releasing Hormone, and Chicken Riboflavin Carrier Protein 
for Inhibiting Reproduction in Coturnix Quail 
C. A. yoder,*t1 W. F. Andelt,t L. A. Miller,* J. J. Johnston,* and M. J. Goodall* 
*National Wildlife Research Center, 4101 Laporte Avenue, Fort Collins, Colorado 80521-2154; and +Department of Fishery 
and Wildlife Biology, Colorado State University, Fort Collins, Colorado 80523 
ABSTRACT Contraception may provide a useful nonle- 
thal management tool when it is desirable to reduce popu- 
lations of birds. We tested the efficacy of 20,25 
diazacholesterol, and immunization with avian gonado- 
tropin-releasing hormone (AGnRH-I) and chicken ribofla- 
vin carrier protein (cRCP) as contraceptives and 
investigated their modes of action in Coturnix quail (Co- 
turnix coturnix japonica). Females that were paired with 
males treated with 20,25 diazacholesterol produced lower 
percentages of eggs that were fertile and hatched. Females 
treated with 20,25 diazacholesterol and paired with con- 
trol males laid fewer eggs, and lower percentages of their 
eggs were fertile and hatched. Treatment with 20,25 dia- 
zacholesterol reduced testosterone levels in males and 
progesterone levels in females. Nonesterified cholesterol 
levels were reduced, whereas desmosterol levels in- 
creased in birds treated with 20,25 diazacholesterol. Treat- 
ment with AGnRH-I and cRCP immunocontraceptive 
vaccines did not decrease average egg production and 
hatchability or hormone levels, but this failure might have 
been due to the vaccination protocol. If registered, wildlife 
managers may be able to use 20,25 diazacholesterol when 
other methods, such as lethal control, are undesirable for 
reducing damage caused by specific breeding behaviors 
such as the building of nests. 
(Key words: avian gonadotropin-releasing hormone, chicken riboflavin carrier protein, 
20,25 diazacholesterol, immunocontraception, reproductive inhibition) 
2004 Poultry Science 83:234-244 
INTRODUCTION 
Birds cause numerous conflicts including consumption 
of food crops (White et al., 1985; Dolbeer et al., 1986; 
Wilson et al., 1989), fruits and vegetables (Clark, 1986), 
livestock feed (Glahn, 1982; Glahn and Otis, 1986), and 
fish at aquaculture facilities (Parkhurst et al., 1987; Stick- 
ley et al., 1995; Andelt et al., 1997). Birds also cause public 
health concerns by transmitting disease (Gough and 
Beyer, 1982; Glahn and Stone, 1984) and safety concerns 
by striking aircraft (Dolbeer, 1989; Conover et al., 1995). 
Care must be taken in selecting and using techniques that 
resolve conflicts because the public has concern about 
lethal control techniques. Contraception is a possible non- 
lethal alternative that is more acceptable to the general 
public than lethal control measures (Arthur, 1981; Mes- 
smer et al., 1997; Stout et al., 1997). 
A number of contraceptives have been tested in birds, 
but several, such as the synthetic estrogen BDH10131 
(Kendle et al., 1973), mestranol (Wentworth, 1968; Went- 
worth et al., 1968; Sturtevant, 1970), a-chlorohydrin (Aire 
and Olusanya, 1980), triethylenemelamine (TEM) (Davis, 
1961; Vandenbergh and Davis, 1962; Messersmith, 1971; 
Bhat and Maiti, 1989), thiotepa (Potvin et al., 1982), and 
surgical sterilization (Converse and Kennelly, 1994), have 
produced unacceptable results. The desirable qualities of 
any wildlife contraceptive are that it last for one breeding 
season with a minimal number of days of treatment and 
that it be reversible so as not to permanently remove the 
animals from the gene pool. In addition, for practical 
reasons, the contraceptive should be oral to eliminate the 
need to capture animals and must be relatively inexpen- 
sive (Turner and Kirkpatrick, 1991; Garrott, 1995). Mestra- 
nol, a-chlorohydrin, and TEM might possibly 
permanently sterilize adults and young being fed by crop 
milk. Thiotepa and BDH10131 are associated with a lim- 
ited duration of effect that requires an extended treatment 
Abbreviation Key: AGnRH-I = avian gonadotropin-releasing hor- 
02004 Poultry Science Association, Inc. mone; cRCP = chicken riboflavin carrier protein; FCA = Freund's com- 
Received for publication June 5, 2003. plete adjuvant; FIA = Freund's incomplete adjuvant; FSH = follicle- 
Accepted for publication September 10, 2003. stimulating hormone; GnRH = gonadotropin-releasing hormone; KLH = 
'TO whom correspondence should be addressed: christi.yoder@ keyhole limpet hemocyanin; LH = luteinizing hormone; TEM = triethyl- 
usda.gov. enemelamine. 
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period to cover the breeding season. Surgical sterilization 
is prohibitively expensive. 
The cholesterol inhibitor 20,25 diazacholesterol is a 
promising contraceptive because, in contrast to immuno- 
contraceptives that currently must be injected, it can be 
delivered orally. Research on the efficacy of 20,25 diaza- 
cholesterol produced conflicting results with red-winged 
blackbirds (Agclauis plzoetzice~rs) (Fringer and Granett, 
1970; Lacombe et al., 1986, 1987, 1990), pigeons (Columba 
liuia) (Schortemeyer and Beckwith, 1970; Sturtevant and 
Wentworth, 1970), house sparrows (Passer doniesticus) 
(Sanders and Elder, 1976; Mitchell et al., 1979), grackles 
(Quiscallls quisctrla) (Fringer and Granett, 1970), Japanese 
quail (Coturnix coturnix japonica), and parakeets (probably 
Melopsittacus trndlrlatus) (Powell, 1966). Conclusions from 
these studies were limited because little physiological 
work with hormone levels was conducted to determine 
the mode of action of the compound. 
Immunocontraception acts on the animal's immune 
system to control reproduction. Gonadotropin-releasing 
hormone (GnRH) is a promising antigen for use as an 
immunocontraceptive vaccine. Antibodies generated 
against avian GnRH (AGnRH-I) or GnRH were effective 
in inhibiting reproduction in cowbirds (Molotlzrt~s atev; 
Thompson et al., 1994), starlings (L. A. Miller, 2000, 
USDA/APHIS/WS/NWRC, personal communication), 
and several species of mammals (Ladd et al., 1988; Awon- 
iyi et al., 1993; Meloen et al., 1994). The amino acid se- 
quence of AGnRH-I differs from mammalian GnRH by 
one amino acid, which may confer some avian specificity. 
Mammalian GnRH vaccines were effective for 2 1 yr in 
rats (Rattus noruecyictrs) (Miller et al., 1997) and 2 2 yr in 
white-tailed deer (Odocoilet~s vircyinianus) (Miller et a]., 
2000), which may make AGnRH-I suitable for use as an 
immunocontraceptive lasting at least one breeding season 
in birds. 
Another promising antigen for use in an immunocon- 
traceptive vaccine is chicken riboflavin carrier protein 
(cRCP). Antibodies to cRCP inhibited reproduction in lab 
mice (inbred Swiss strain; Natraj et al., 1994) and common 
marmosets (Cnllithrix jaccllus; Natraj, 1991). Immunologi- 
cal homologues to cRCP were demonstrated in lab mice 
and rats (Muniyappa and Adiga, 1980; Natraj et al., 1987), 
primates (Mncaca rarliata; Visweswariah and Adiga, 1987a; 
Callitllrix jacdlus; Natraj and Kholkute, 1989), and humans 
(Natraj et al., 1987; Visweswariah and Adiga, 1987%). A 
cRCP vaccine may be preferable to other contraceptive 
agents because it should not interfere with reproductive 
and territorial behaviors. No research has previously been 
conducted to test the effect of antibodies to cRCP on 
reproduction of birds. 
Our objectives were to assess the efficacy of 20,25 diaza- 
cholesterol and immunization with AGnRH-I-keyhole 
limpet hemocyanin (KLH) and cRCP-KLH in Coturnix 
quail by measuring numbers of eggs produced, fertility, 
and hatchability of eggs. Our objectives also were to docu- 
ment the effects of all 3 contraceptives on testosterone and 
progesterone levels; the effect of 20,25 diazacholesterol on 
cholesterol, desmosterol, and corticosterone levels; the 
effect of AGnRH-I on corticosterone levels; and the ability 
of AGnRH-I and cRCP to induce an antibody response. 
We proposed that 20,25 diazacholesterol would reduce 
fertility by preventing side chain cleavage of cholesterol 
or reduce cholesterol levels directly by preventing the 
conversion of desmosterol to cholesterol (Dietert and Scal- 
len, 1969; Counsel1 et al., 1971; Emmons et al., 1982). 
Cholesterol is the parent compound for steroid hormones, 
which include the reproductive hormones testosterone 
and progesterone. We hypothesized that the block of des- 
mosterol to cholesterol would result in increased des- 
mosterol and decreased cholesterol and, therefore, 
decreased testosterone, progesterone, and corticosterone, 
thus reducing egg production and fertility. 
We proposed that vaccination with AGnRH-I vaccine 
would create antibodies to native AGnRH-I. In the male, 
treatment with AGnRH-I should indirectly lower testos- 
terone levels through its effect on follicle-stimulating hor- 
mone (FSH) and luteinizing hormone (LH), thus lowering 
sperm prndi~rtion and red~icing fertility and hatchability. 
In females, treatment with AGnRH-I should lower FSH 
and LH levels, reducing follicular development, thus indi- 
rectly reducing progesterone levels and egg production. 
Because the AGnRH-I vaccine may affect copulatory be- 
havior, we predicted that treated females might lay a 
lower percentage of fertile eggs. In birds, corticosterone is 
formed from progesterone, thus we predicted decreased 
progesterone could also decrease corticosterone. We did 
not expect a reduction in testosterone to have any effect 
on corticosterone levels. 
We proposed that vaccination with cRCP vaccine 
would create antibodies to native cRCP, thus blocking 
riboflavin binding to the riboflavin transport protein and 
preventing storage of riboflavin. We proposed this block 
would cause embryos of treated birds to consistently die 
at an early stage because riboflavin is essential for embry- 
onic development, and so a lower percentage of eggs 
would hatch in the treated group than in the control 
group. We predicted that treatment would have no effect 
on progesterone levels and therefore would not affect the 
number or fertility of eggs laid by treated females. 
Coturnix quail were used in this study because, in con- 
trast to many wild species of birds, Coturnix quail repro- 
duce readily in captivity, and their reproductive cycles are 
easily manipulated by changing the photoperiod (Padgett 
and Ivey, 1959; Wilson et al., 1962; Schafer et al., 1977). 
Testicular regression can be induced using a 6L:18D light 
cycle, and testicular development can be induced using 
a 16L:BD light cycle (Schafer et al., 1977). Egg production 
can be reduced by decreasing the number of hours of 
light exposure (Wilson et al., 1962). Coturnix quail are 
sexually mature at 42 d, and mature females can lay I 
300 eggs per year in the laboratory (National Academy 
of Sciences, 1969). Coturnix quail exhibit reproductive 
seasonality in natural settings (National Academy of Sci- 
ences, 1969; Wada, 1979). Once the male is removed from 
the female, sperm can be stored and is viable in the female 
reproductive tract for 6 to 9 d (Sittman and Abplanalp, 
1965; Woodard and Abplanalp, 1967). 
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MATERIALS AND METHODS 
The experimental protocol was reviewed by the Colo- 
rado State University and National Wildlife Research 
Center's Animal Care and Use Committees and complied 
with the Animal Welfare Act. The experiment consisted 
of 1) 20 female Coturnix quail treated with 20,25 diaza- 
cholesterol%nd paired with 20 untreated males, 2) 20 
males treated with 20,25 diazacholesterol and paired with 
20 untreated females, 3) 20 females vaccinated with 
AGnRH-I-KLH and paired with 20 untreated males, 4) 
20 males vaccinated with AGnRH-I-KLH and paired with 
20 untreated females, 5) 20 females vaccinated with cRCP- 
KLH and paired with 20 untreated males, and 6) a control 
group of 20 untreated males paired with 20 untreated 
females. The untreated members of each group were used 
to provide fertility and hatching data. Birds were weighed 
and separated by sex. Six of the heaviest of 120 females 
were randomly assigned to each of 6 treatment groups, 
then the next 6 heaviest females were randomly assigned 
to groups, and so on until each group contained 20 fe- 
males. The same procedure was used for the males. Ten 
birds of each sex from each treatment group were ran- 
domly assigned to each of 2 experimental rooms. Birds 
within treatment groups were then randomly assigned 
to pairs. Pairs of birds from the same treatment groups 
were randomly assigned to cage racks and to cages within 
racks. All birds were 8 wk of age at the beginning of the 
study (at pretreatment wk 1). Birds were maintained on 
a 16L:8D light cycle, which we determined in a pilot study 
to be the optimal light cycle for peak sex hormone levels 
(Yoder, 2000). Quail were maintained on a layer diet9hat 
consisted of 3.6 to 4.6% calcium, 2 0.5'%) phosphorus, 2 
l6'% crude protein, and 2.88 kcal/g metabolizable energy. 
We drew 500 /IL of blood from the jugular vein of 
each bird treated with 20,25 diazacholesterol and from 
all control birds once each week for 3 wk pretreatment 
(at 8, 9, and 10 wk of age), once per week for 2 wk of 
treatment (at 11 and 12 wk of age) and 8 wk posttreatment 
(at 13 to 21 wk of age), and then once every 2 wk for 11 
wk. We drew 500 / tL of blood from the jugular vein of 
AGnRH-I- and cRCP-treated birds once each week for 3 
wk pretreatment (at 8,9, and 10 wk of age); once each in 
wk 7 (at 14 wk of age), wk 11 (at 18 wk of age), and wk 
13 (at 20 wk of age); and then once every 2 wk for 11 wk. 
Birds in the AGnRH-I and cRCP groups were held as if 
for bleeding, but no blood was drawn during wk 4, 5, 6, 
8, 9, 10, and 12. Females were bled starting at 1300 h, 
which was pre\liously determined in a pilot study to be 
when peak progesterone levels occurred (Yoder, 2000). 
The 500 /IL of blood represents < l'X1 of body ~reiglit or 
5 3.5%) standing blood volume. We be1ieL.e this removal 
of blood did not ad\rersely affect the birds because starling 
'i-\\.ltrol Corp., Tulsa, OK. 
'~'urina M~lls ,  Inc., St. Louis, MO. 
' ~ a c r o r n o l e c ~ ~ l ; l r  Resources, Fort Collins, CO. 
'Pierce Cliernic'll Co., Rockford, IL. 
" C a l b i o c l ~ e m - ~ o \ ~ a L ~ i ~ ~ c l ~ e ~ ~ ~  Corp., La Jolla, CA 
chicks (Clark, 1991) and adult pigeons (Kovach and Szasz, 
1968) survived daily blood losses of approximately 20 to 
85'% of the standing blood volume (7%) of body 
weight), respectively. 
Immediately following the 3-wk pretreatment, all fe- 
males scheduled for treatment were randomly assigned 
to males scheduled for treatment; all females scheduled 
to be untreated were randomly assigned to males sched- 
uled to be untreated, and control birds were randomly 
rearranged in pairs. Pairs were caged together (one female 
and one male per cage) and fed treated or control bait. 
This rearrangement of pairs was necessary to feed treated 
bait because of space limitations. At the end of treatment, 
birds were returned to their original pair groups. Quail 
in the AGnRH-I and cRCP groups were maintained on 
Purina game bird layer ration. Quail in the 20,25 diaza- 
cholesterol group were maintained on the same diet ex- 
cept for the addition of 20,25 diazacholesterol to the feed 
during the treatment period. 
We formulated bait to contain 0.l0X 20,25 diazacholest- 
erol by weight of total dry feed because Elder (1964) and 
Woulfe (1967) reported that concentrations lower than 
0.l0/o were ineffective, and higher concentrations pro- 
duced signs of mild toxicity. We created a mash using 
water and the pelleted food normally fed and then mixed 
in the 20,25 diazacholesterol. Woulfe (1967) reported that 
20,25 diazacholesterol was effective when fed to birds for 
5 d, and he did not recommend feeding for >16 d due to 
toxic effects. We fed the treated mash to quail in the 20,25 
diazacholesterol group, as the sole source of food, for 14 
d during wk 4 and 5 to 50% of the birds in treatment 
groups, but because they exhibited signs of toxicity, we 
fed the remaining 25 and 25% of the birds for 13 and 12 
d, respectively. This procedure resulted in 10 males and 
10 females fed treated bait for 14 d, 5 males and 5 females 
fed treated bait for 13 d, and 5 males and 5 females fed 
treated bait for 12 d. Data were combined regardless of 
the length of treatment for analysis. Control birds were 
fed the same product without the 20,25 diazacholesterol. 
Uneaten bait was weighed each day. We calculated the 
average dose of 20,25 diazacholesterol fed to each bird 
each day post hoc as described in Yoder (2000). Quail 
were weighed once a week during the treatment period 
and once every 2 wk thereafter to ascertain if weight 
loss occurred. 
Primary and booster AG~RH-1' and cRCp4 vaccines 
were prepared according to the method described by the 
manufacturer for maleimide-activated keyhole limpet he- 
mocyanin (KLH) .~  In wk 3, birds in the AGnRH-I treat- 
ment group were given a 0.3-mL primary vaccination of 
100 /lg of AGnRH-I-KLH conjugate in Freund's complete 
adjuvant (FCA)," and cRCP birds were given a 0.3-mL 
primary l~accination of 100 /rg of cRCP-KLH conjugate in 
FCA. Two 0.3-mL booster vaccinations consisting of 100 
/ ~ g  of AGnRH-I-KLH conjugate in Freund's incomplete 
adjuvant (FIA)" or 100 11g of cRCP-KLH conjugate in FIA 
were gilnen to the respective groups during wk 7 and 11. 
Control birds were sham vaccinated with 0.15 mL of sa- 
line in 0.15 mL of FCA or FIA. Vaccinations were given 
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subcutaneously in 4 areas of the breast. Quail were 
weighed once every 2 wk to ascertain if weight loss oc- 
curred. 
Because sperm can remain viable in the reproductive 
tract of female quail for 5 9 d (Sittman and Abplanalp, 
1965; Woodard and Abplanalp, 1967), we did not begin 
collecting eggs to determine fertility and hatchability for 
the 20,25 diazacholesterol groups until 1 wk after treat- 
ment ceased due to the necessary rearrangement of pairs 
for treatment purposes. We did not expect any effects on 
fertility and hatchability from the AGnRH-I and cRCP 
vaccines until 2 2 wk after the last booster vaccine was 
given, thus we began collecting eggs 3 wk after the last 
vaccination. Eggs were collected and incubated to deter- 
mine viability of the embryos and chicks. Unhatched eggs 
were opened after the expected hatching date to deter- 
mine fertility. The stage of development of the embryo 
at death was determined for the cRCP and control groups 
only according to Padgett and Ivey (1960). Fertility was 
defined as the presence of an embryo or a blastodisc. 
Eggs were considered to be infertile if neither an embryo 
nor a blastodisc could be located or the egg had degraded 
to the point that such a determination was not possible. 
We determined plasma progesterone, testosterone, and 
corticosterone levels for all treatment and control groups 
using a solid-phase I ' ~ ~  RIA technique with antibody- 
coated tubes7 and a Genesys 5000 series multiwell ?- 
~ o u n t e r . ~  Desmosterol and nonesterified cholesterol lev- 
els were determined for the 20,25 diazacholesterol groups 
using HPLC following the procedure of Johnston et al. 
(2001). Antibody titer levels were determined for the 
AGnRH-I and cRCP groups using an ELISA technique 
developed at the National Wildlife Research Center 
(Yoder, 2000). 
Statistical Analyses 
We divided the study into pretreatment (1 to 3 wk) 
and treatment and posttreatment (4 to 23 wk) phases for 
comparisons among diazacholesterol and control groups. 
Data were combined for the diazacholesterol groups re- 
gardless of the length of treatment. We also divided the 
study into pretreatment (1 to 3 wk), priming (4 to 7 wk), 
first boost (8 to 11 wk), and second boost (12 to 24 wk) 
phases for comparisons among AGnRH-I, cRCP, and con- 
trol groups. We used a one-way ANOVA (PROC GLM; 
SAS Institute Inc., 1988), and P < 0.05 for all analyses. 
The mean percentage of fertile eggs was calculated by 
combining the number of eggs that hatched and the num- 
ber of eggs that were fertile (either by the presence of 
an embryo or blastodisc) post expected hatching date, 
dividing this number by the total number of eggs set, 
and multiplying the result by 100. The mean number of 
eggs that hatched was calculated by diiriding the number 
Product numbers TKPG1, TKTT1, and TKRCI, respectively, Diag- 
nostic Products Corp., Los Angeles, CA. 
'Laboratory Technologies lnc., Schaumburg, IL. 
- Control - - DiazaCon 
Week of study 
FIGURE 1. Fertility of eggs laid by 20 untreated female Coturnix quail 
paired with 20 males treated w t h  20,25 diazacholesterol (DiazaCon) 
compared with eggs of 20 untreated female quail paired wit11 20 male 
controls at the National Wildlife Research Center, Fort Collins, Colorado, 
January to July 1997. Note that quail were 12 wk of age during treatment 
w k  4. LSD = least significant difference. 
of eggs that hatched by the number of eggs set and multi- 
plying the result by 100. We divided the incubation period 
into 6 stages of embryonic development, incubation 1 to 
3 d, 3 to 6 d, 6 to 9 d, 9 to 12 d, 12 to 15 d, and 15 to 17 
d, and assigned each embryo to a stage of development 
at death. We compared average stage of development at 
death among the cRCP and control groups using a one- 
tailed ANOVA. Only weeks that eggs were incubated to 
term were used for this analysis. 
Because pretreatment levels of testosterone and cortico- 
sterone varied among birds, we averaged the 3 pretreat- 
ment values for each bird, subtracted this value from the 
response mean of 4 to 23 wk by bird for the diazacholest- 
erol and control group comparisons and from the mean 
of each of the subsequent phases for AGnRH-I, cRCP, 
and control group comparisons. We compared the testos- 
terone differences among treatment and control groups, 
and the corticosterone differences among the control and 
20,25 diazacholesterol groups and among the control and 
female AGnRH-I groups using a one-tailed or two- 
tailed ANOVA. 
- Control - - DiazaCon - female 
Week of study 
FIGURE 2. Egg production of 20 female Coturnix quail treated ~aitli 
20,25 diazacholesterol (DiazaCon) and 20 female control quail at the 
National Wildlife Research Center, Fort Collins, Colorado, January to 
July 1997. Note that qua11 Ivere 12 ~ v k  of age during treatment \vk 1. 
LSD = least significant difference. 
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TABLE 1. Fertility, hormone, cholesterol, and desmosterol levels and weight for males treated 
with 20,25 diazacholesterol and control Coturnix quail at the National Wildlife 
Research Center, Fort Collins, Colorado, January to July 1997 
20,25 Diazacholesterol Control 
- - 
n x SE n x SE P' 
- - 
I'ercentage of fertile eggs2 17 42.0 6.0 20 71.0 5.0 10.001 
Percentage of eggs hatched' 17 23.0 4.0 20 37.0 4.0 0.012 
Change in testosterone ( ~ ~ g / r n L ) ' , ~  20 -0.95 0.27 20 0.13 0.17 0.001 
Nonesterified cholesterol (icg/mL) 17 203.79 21 . I1  19 331.43 20.63 <0.001 
Desmosterol (/cg/mL) 17 232.59 40.58 19 7.32 1.81 10.001 
Change in bodv weight (g)7,' 20 6.00 3.39 20 22.18 2.11 10.001 
'All P-values are I-tailed except the P value for weight m~hich is 2-tailed 
'obtained from females paired with treated males. Values are for the combined treatment and posttreatment 
period (4 to 23 wk). 
'Values were obtained by subtracting the pretreatment means from the combined treatment and posttreatment 
means (4 to 23 wk). 
'7he average testosterone level was 3.41 ng/mL (SE = 0.21) for the control group and 2.15 ng/mL (SE = 0.19) 
for the 20,25 diazacholesterol group during the combined treatment and posttreatment period (4 to 23 wk). 
'Average weight was 181.55 g (SE = 3.36) for the control group and 168.41 g (SE = 3.74) for the 20,25 
diazacholesterol group during the combined treatment and posttreatment period (4 to 23 wk). 
Progesterone did not vary among birds during pre- 
treatment, thus we compared the mean for 4 to 23 wk 
among the diazacholesterol and control groups and the 
mean for the priming, first boost, and second boost phases 
among the AGnRH-I and control groups and among the 
cRCP and control groups by using a one-tailed or two- 
tailed ANOVA. We averaged wk 3, 4, 5, 6, 7, and 23 to 
obtain mean desmosterol and nonesterified cholesterol 
levels and then compared means among the diazacholest- 
erol and control groups using a one-tailed ANOVA. We 
compared mean antibody titers among the AGnRH-I and 
control groups and among the cRCP and control groups 
using a one-tailed ANOVA for the priming, first boost, 
and second boost phases. 
We subtracted the pretreatment weights of birds from 
the mean of 4 to 23 wk for the diazacholesterol and control 
groups and from the mean of each of the subsequent 
phases for the AGnRH-I, cRCP, and control groups and 
compared the differences among treatments using a two- 
tailed ANOVA. We used PROC CORR to analyze the 
correlation between average dose per individual and tes- 
tosterone, progesterone, desmosterol, nonesterified cho- 
lesterol, the numbers of eggs laid, and the percentages of 
eggs that hatched or were fertile for the 20,25 diaza- 
cholesterol and control groups. 
RESULTS 
20,25 Diazacholesterol Males 
The percentage of eggs that were fertile and hatched 
were reduced by 20,25 diazacholesterol in treatment com- 
pared with control groups (Figure 1, Table 1). Testoster- 
one levels decreased more in treated males than in control 
males. Differences in corticosterone levels did not vary 
between treatment and control males (P = 0.376). Nones- 
terified cholesterol levels were lower in treated males 
than in control males. Desmosterol levels were greater in 
treated males than in control males. Control males gained 
more weight than treated males during wk 4 to 23. The 
average dose of 20,25 diazacholesterol per male per day 
was 59.42 mg/kg (range = 0.01 to 101.40 mg/kg). Dose 
was negatively correlated with testosterone levels and 
the percentage of eggs that were fertile (P = 0.0002), nones- 
terified cholesterol levels (P = <0.0001), and percentage 
of eggs that hatched (P = 0.0015). Dose was positively 
correlated with desmosterol levels (P = 0.0002). 
20,25 Diazacholesterol Females 
The number of eggs laid per female per week and the 
percentages of eggs that were fertile and hatched were 
reduced by 20,25 diazacholesterol in treatment compared 
with control groups (Figure 2, Table 2). Progesterone and 
nonesterified cholesterol levels were lower in treated fe- 
males than in control females. Differences in corticoste- 
rone levels did not vary between treatment and control 
females (P = 0.895). Desmosterol levels were higher in 
treated females than in control females. Control females 
gained more weight than treated females during wk 4 to 
23. The average dose of 20,25 diazacholesterol per female 
per day was 61.03 mg/kg (range = 1.47 to 103.37 mg/ 
kg). Dose was negatively correlated with progesterone 
levels (P = 0.05), nonesterified cholesterol and the number 
of eggs laid per female per week (P = <0.0001), the percent- 
age of eggs that were fertile (P = 0.0458), and the percent- 
age of eggs that hatched (P = 0.0001). Dose was positively 
correlated with desmosterol (P = <0.0001). 
A Gn RH-I Males 
The percent of eggs that were fertile did not vary be- 
tween treated and control males (Table 3). The percentage 
of eggs that hatched was marginally lower in the treat- 
ment compared with the control group. Changes in testos- 
terone levels from pretreatment values did not differ 
between the treated and control males during the priming 
and first boost phases, but testosterone decreased more 
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TABLE 2. Fertility, hormone levels, cholesterol and desmosterol levels, and weight for females treated 
with 20,25 diazacholesterol and control Coturnix quail at the National Wildlife Research Center, 
Fort Collins, Colorado, January to July 1997 
20,25 diazacholesterol Control 
- - 
x SE n n x SE P' 
Number of eggs laid 
per female per week2 20 0.65 0.17 19 1.50 0.25 <0.001 
Percentage of fertile eggs 9 21 .0 11.0 19 70.0 5.0 s0.001 
Percentage of eggs liatched 9 0.0 0.0 19 36.0 4.0 <0.001 
Progesterone (ng/mL) 20 0.45 0.06 19 0.77 0.08 0.002 
Nonesterified cholesterol (jig/mL) 18 224.41 26.50 19 161.70 44.06 50.001 
Desmosterol ( j~g/niL) 18 283.67 29.60 19 32.36 3.36 <0.001 
Change in body weight (g)' 2 0 -0.70 1.97 19 20.90 3.56 0.001 
'All P-values are 1-tailed except the P-value for weight, which is 2-tailed. 
'Values are for the combined treatment and posttreatment period (4 to 23 wk) .  
' ~ v e r a g e  weight was 204.86 g (SE = 5.27) for the control group and 184.13 (SE = 4.75) for the 20,25 diazacholest- 
erol group for the combined treatment and posttreatment period (4 to 23 wk). 
in treated males than in control males during the second 
boost phase. Changes in corticosterone did not differ be- 
tween treated and control males from pretreatment values 
during the priming phase (P = 0.952), first boost phase 
(P = 0.194), and second boost phase (P = 0.936). Changes 
in body weight from pretreatment values during the 3 
phases did not differ between treated and control males. 
Treated males had antibody titers of 3,711 during the 
priming phase, 7,789 during the first boost phase, and 
9,061 during the second boost phase. Control males had 
no antibody titers during all 3 phases. 
A Gn RH-I Females 
The number of eggs laid per female per week during 
all 3 phases and the percentage of eggs that were fertile 
and hatched during the second boost phase did not differ 
between treated and control females (Table 4). Progester- 
one levels did not differ between treated and control fe- 
males in the priming and first boost phases, but 
progesterone levels were lower in treated females than 
in control females during the second boost phase. 
Changes in corticosterone from pretreatment levels did 
not differ between treated and control females during the 
priming phase (P = 0.750), first boost phase (P = 0.257), 
or second boost phase (P = 0.974). Treated females gained 
more weight than control females during the priming, 
first boost, and second boost phases. Treated females had 
antibody titers of 2,025 during the priming phase, 8,625 
during the first boost phase, and 7,275 during the second 
boost phase. Control females had no antibody titers dur- 
ing all 3 phases. 
TABLE 3. Fertility, hormone levels, and weights for males treated with AGnRH-I' 
and control Coturnix quail at the National Wildlife Research Center, 
Fort Collins, Colorado, January to July 1997 
AGnllH-I Control 
- - 
n x SE Parameter and phase n x SE P? 
Percentage of fertile eggs7 18 56.0 7.0 20 62.0 7.0 0.250 
Percentage of eggs hatched7 18 14.0 3.0 20 24.0 5.0 0.066 
Change in testosterone (~ig/mL) 
Prime4,' 19 -0.05 0.27 20 0.09 0.17 0.336 
First boost",' 19 0 . 5 3  0.35 20 -0.06 0.19 0.118 
Second boost4,' 19 -0.38 0.31 20 0.03 0.20 0.038 
Change in body weight (g) 
Prime'," 19 18.55 3.67 20 13.00 1.94 0.184 
First boost"," 19 28.12 3.01 20 23.10 2.81 0.258 
Second boost"," 19 30.29 3.38 20 29.04 2.86 0.779 
' ~ v i a n  gonadotropin releasing hormone-I. 
' ~ l l  P-values are 1-tailed except P-values for weight and corticosterone, which are 2-tailed. 
' ~ a l u e s  are for 11 to 21 wrk and were obtained from females paired with treated males. 
'Values were obtained by subtracting the pretreatment means from each of the phase means (priming, first 
boost, and second boost phases). 
'Average testosterone levels for the priming, first boost, and second boost phases were 3.37 ng/mL (SE = 
0.19), 3.22 ng/mL (SE = 0.19), and 3.58 ng/mL (SE = 0.27), respectively, for the control group and 2.69 ng/mL 
(SE = 0.29), 2.21 ng/mL (SE = 0.39), and 2.36 ng/mL (SE = 0.32), respectively, for the AGnRH-I group. 
"Averdge weights for the priming, first boost, and second boost phases were 172.37 g (SE = 2.96), 182.78 g 
(SE = 4.01), and 188.11 g (SE = 3.99), respectively, for the control group and 176.68 g (SE = 3.20), 187.35 g (SE = 
3.41), and 190.99 g (SE = 3.91) respect~vely for the AGnRH-I group. 
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TABLE 4. Fertility, hormone levels, and weights for females treated with AGnRH-1' 
and control Coturnix quail at the National Wildlife Research Center, 
Fort Collins, Colorado, January to July 1997 
AG~RH-I '  Control 
- - 
x SE Parameter and phase n n x SE P2 
Number of eggs l a d  
per female per week 
P r~me  
F~rst  boost 
Second boost 
Percentage of fert~le eggs3 
Percentage of eggs hatched' 
I'rogesterone (ng/mL) 
Prime 
First boost 
Second boost 
Change in body weight (g) 
Prime4,' 
First boost4,' 
Second boost',' 
'Avian gonadotropin-releasing hormone-I. 
' ~ l l  P-values are 1-tailed except P-values for weight, which are 2-tailed 
'values are for 13 to 24 wk 
'values were obtained by subtracting the pretreatment means from each of the phase means (priming, first 
boost, and second boost phases). 
'Average weights for the priming, first boost, and second boost phases were 198.36 g (SE = 5.08), 210.85 g 
(SE = 6.01), and 211.75 g (SE = 6.13), respectively, for the control group and 213.93 g (SE = 3.36), 225.82 g (SE = 
5.56), and 224.68 g (SE = 6.18), respectively, for the AGnRH-I group. 
cRCP Females 
The proportion of eggs that were fertile and hatched 
and the average stage of embryonic development at death 
did not vary between treated and control birds during 
the second boost phase (Table 5). The number of eggs 
laid per female per week and progesterone levels did not 
differ between treated and control birds during the 3 
phases. Changes in body weight from pretreatment val- 
ues did not vary between the treatment and control fe- 
males during the 3 phases. Treated birds had higher 
antibody titers of 6,658 during the priming phase, 5,059 
during the first boost phase, and 8,808 during the second 
boost phase. Control birds had no antibody titers during 
any of the 3 phases. 
DISCUSSION 
20,25 Diazacholesterol 
The decrease of testosterone in treated males and the 
decrease in percentage of fertile eggs laid by their mates 
suggests 20,25 diazacholesterol indirectly caused a reduc- 
tion in spermatogenesis through lowered testosterone 
le\rels, as reported by Lacombe et al. (1986, 1987) in red- 
winged blackbirds. Powell (1966) also observed a lower 
percentage of fertile eggs laid by female Coturnix quail 
paired with treated males. Wofford and Elder (1967) ob- 
served complete inhibition of reproduction for 5 to 7 mo 
in pigeons fed 0.1% 20,25 diazacholesterol. 
Lower levels of progesterone in 20,25 diazacholesterol 
treated females likely contributed to the reduction in egg 
laying (Figure 2) because progesterone is necessary for 
ovulation (Johnson, 2000). Powell (1966) and Wofford and 
Elder (1967) noted reductions in the rate of laying by 
20,25 diazacholesterol-treated female Coturnix quail and 
female pigeons, respectively. One explanation may be 
that preovulatory follicles in females treated with 20,25 
diazacholesterol may not produce enough progesterone 
and thus become atretic. Powell (1966) and Sturtevant 
and Wentworth (1970) found an increase in the number 
of atretic follicles in treated female Coturnix quail and 
female pigeons, respectively. Sanders and Elder (1976) 
observed that treated female house sparrows did not have 
mature follicles in the ovary. 
We expected 20,25 diazacholesterol to reduce cortico- 
sterone levels because it is a steroid hormone. We recog- 
nize that corticosterone is difficult to accurately measure 
in the plasma because the stress of handling increases the 
levels. The rise in corticosterone due to handling was not 
of concern here but rather a marked decrease in corticoste- 
rone levels, which would indicate that 20,25 diazacholest- 
erol impaired corticosterone production. However, 
because corticosterone levels were similar in treatment 
and control groups, it is possible that a larger dose of 
20,25 diazacholesterol is needed to affect this hormone. 
Corticosterone occurs at higher levels than reproductive 
hormones and thus may not be as sensitive to treatment. 
Another possibility is that 20,25 diazacholesterol may be 
preferentially deposited in reproductive tissues rather 
than in adrenal tissue. Based on these results, it seems 
unlikely that treatment at suggested levels will negatively 
affect corticosterone, which is a stress hormone involved 
in the fight-or-flight response. 
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TABLE 5. Fertility, stage of embryonic development at death, hormone levels, and weights 
for females treated with CRCP' and control Cotumix quail at the National 
Wildlife Research Center, Fort Collins, Colorado, January to July 1997 
cRCP Control 
- - 
n x SE Parameter and phase n x SE P' 
Percentage of fertile eggs7 17 70.0 5.0 15 59.0 7.0 0.188 
Percentage of eggs hatched" 17 14.0 4.0 15 17.0 3.0 0.708 
Number of eggs laid 
per female per week 
Prime 20 5.57 0.21 19 5.00 0.28 0.117 
First boost 19 4.92 0.25 17 4.32 0.35 0.168 
Second boost 18 4.50 0.27 15 4.43 0.17 0.826 
A~rerage stage of embrvonic 
development at deathi' 17 1.22 0.20 15 1.63 0.25 0.106 
Progesteroi~e (ng/mL) 
Prime 20 0.80 0.16 19 0.72 0.10 0.678 
First boost 18 0.67 0.14 16 0.76 0.09 0.585 
Second boost 18 0.79 0.11 15 0.81 0.08 0.854 
Change in body weight (g) 
prime4,' 2 0 24.44 3.91 19 14.41 3.12 0.054 
First b o o ~ t ~ , ~  19 32.98 3.69 16 28.70 4.22 0.510 
Second boost4.' 18 33.80 4.73 15 29.42 4.20 0.502 
'Chicken riboflavin carrier protein. 
 he P-values for weight, progesterone, number of eggs laid, and percentage of fertile eggs are 2-tailed. The 
P-values for the percentage of eggs hatched and average stage of embryonic development are 1-tailed. 
' ~ a l u e s  are for 14 to 24 wk. 
'Values were obtained by subtracting the pretreatment means from each of the phase means (priming, first 
boost, and second boost phases). 
'Average weights for the priming, first boost, and second boost phases were 198.36 g (SE = 5.08), 210.85 g 
(SE = 6.01), and 21 1.75 g (SE = 6.13), respectively, for the control group and 207.28 g (SE = 3.59), 215.77 g (SE = 
1.33), and 217.35 g (SE = 1.59), respectively, for the cRCP group. 
The increase in desmosterol while nonesterified choles- 
terol decreased in treated birds indicated that 20,25 diaza- 
cholesterol may act as an antagonist to the ~~ ' - reductase  
enzyme, which converts desmosterol to cholesterol, as 
suggested by Dietert and Scallen (1969) and Emmons et 
al. (1982). However, 20,25 diazacholesterol also may act 
as an antagonist to the cytochrome P450 enzyme, causing 
an inhibition of the side chain cleavage. Counsel1 et al. 
(1971) suggested that inhibition of side chain cleavage 
might be caused by the substitution of a nitrogen for C-25. 
We observed signs of toxicity, such as listlessness, 
weight loss, difficulty breathing, and loss of muscle con- 
trol in some of the 20,25 diazacholesterol-treated birds. 
Eight of 20 treated females and 4 of 20 treated males died 
by wk 9, and the cause of death was suspected to be 
toxic effects of 20,25 diazacholesterol. Only 4 of 20 control 
females and 1 of 20 control males died by wk 9. Necropsies 
of treated birds indicated liver damage such as fatty livers 
and friable livers. Elder (1964), Powell (1966), Woulfe 
(1967), and Sturtevant and Wentworth (1970) also ob- 
served mortality and toxic effects on quail and pigeons 
treated with 20,25 diazacholesterol. Because cholesterol is 
an integral component of cell wall structure, the reduced 
cholesterol may cause toxicity. Ashraf et al. (1984) sug- 
gested that the increased desmosterol levels may contrib- 
ute to an increase in membrane fluidity. Reddy et al. 
(1982) found that 20,25 diazacholesterol has a direct effect 
on muscle fibers, changing them morphologically and 
biochemically, and causes myotonia. We speculate that 
20,25 diazacholesterol may cause cytotoxicity to hepato- 
cytes when it is stored in the liver. The level of mortality 
observed in this study is a concern and highlights the 
need to perform dose-response studies. Other studies on 
red-winged blackbirds (Lacombe et al., 1986) and house 
sparrows (Mitchell et al., 1979) did not show such mortal- 
ity. Feeding for a shorter period of time or lowering the 
dose may give satisfactory results without causing mor- 
tality. 
Further analysis showed that birds treated with 20,25 
diazacholesterol lost weight during the treatment period. 
Treated birds consumed less feed during the treatment 
period because the bait apparently was unpalatable, 
which contributed to weight loss and less weight gain 
overall. Upon removal of the treated bait, birds in the 
treatment group gained weight, and the differences in 
weight were not significant between female groups after 
wk 10 and between male groups after wk 11. Reduced 
consumption of 20,25 diazacholesterol treated bait and 
subsequent weight loss also was noted by Powell (1966) 
and Lacombe et al. (1987). Lacombe et al. (1987) suggested 
that 20,25 diazacholesterol may affect the metabolism of 
birds, contributing in part to weight loss. Although we 
cannot exclude the possibility that weight loss caused 
ovarian regression, we felt the weight loss was not the 
cause of the reduction in egg laying and fertility because 
they continued to be suppressed for 15 wk after birds 
gained weight. Weight loss only constituted a 10%) loss 
in the treatment groups. 
Dose-response work should be conducted on wild spe- 
cies of interest before 20,25 diazacholesterol is tested in the 
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field to determine an effective and nontoxic dose for each 
species. These lab tests should include a gavage study in 
which precise doses are known. Desmosterol and nonester- 
ified cholesterol can be used as markers of efficacy in the 
absence of breeding by wild species in a laboratory setting. 
Dose and plasma values of desmosterol and nonesterified 
cholesterol can then be correlated, and this information can 
be extrapolated to determine dose when 20,25 diazacholest- 
erol is fed ad libitum. Because we could not measure 20,25 
diazacholesterol in the plasma of treated birds, even though 
it can be measured in spiked control plasma samples, a 
specific assay to measure plasma levels of 20,25 diaza- 
cholesterol metabolites is also needed. Because a daily dos- 
ing regimen is required, development of a more practical 
method of delivery that allows for a prolonged release of 
20,25 diazacholesterol in a single dose would be advanta- 
geous. Nontarget and secondary hazards will also need to 
be assessed prior to wide scale use. 
lmmunocontraceptives 
The reduced testosterone levels of AGnRH-I-treated 
males during the second boost phase likely was not biologi- 
cally significant because fertility of treated males was not 
affected, and hatchability was only marginally decreased. 
Several investigators obtained lowered testosterone levels, 
reduced fertility, and reduced libido after vaccinating 
against GnRH in male cattle (Robertson et al., 1982), rats 
(Ladd et al., 1989), male piglets (Meloen et al., 1994), and 
brown-headed cowbirds (Thompson et al., 1994). On aver- 
age, the AGnRH-I antibody titers produced in this study 
likely were not sufficient to reduce testosterone levels 
enough to reduce reproduction. However, 3 of the 20 birds 
responded to the AGnRH-I vaccine by producing antibody 
titers during the second boost phase ranging from 1:32,000 
to 1:128,000, which reduced testosterone to 0 to 3.6 ng/mL 
and reduced fertility for 5 to 12 wk. The failure of the 
vaccine to produce high antibody titers in the majority of 
the birds may be due to the vaccine being metabolized too 
quickly. The vaccine depot must be present for several 
weeks for good antibody production. A route of adminis- 
tration other than subcutaneous vaccination may prevent 
the depot from being metabolized too quickly. The overall 
health of the animal may also affect the immune response. 
However, poor health would also tend to decrease fertility 
and egg production, which was not observed in this study 
and therefore was not a likely explanation for the vac- 
cine failure. 
Lower progesterone levels in AGnRH-I-treated females 
during the second boost phase likely were not biologically 
significant because egg laying was not reduced. On aver- 
age, the AGnRH-I antibody titers produced in this study 
likely were not h g h  enough to reduce progesterone levels 
due to the reasons mentioned above. Esbenshade and Britt 
(1985) found that progesterone and estradiol levels de- 
creased to basal levels, and acyclicity occurred in gilts vacci- 
nated against GnRH. In our experiment, 2 females had 
higher-than-average titers of 1:24,000 and 1:12,000 during 
the second boost phase. These birds did not lay eggs for 
5 and 2 wk, respectively, and had progesterone levels rang- 
ing from 0 to 0.41 ng/mL. Control birds did not have 
antibody titers, and egg production was normal. 
Although the exact cause is unknown, the higher weight 
gain of the AGnRH-I-treated females during the study may 
be due to a reduction in estradiol levels. We did not mea- 
sure estradiol in our study; therefore, it is unclear if t h s  
was the case. Because GnRH affects FSH and LH, it is 
reasonable to expect vaccination against GnRH to lower 
estradiol levels. Because estradiol is the hormone responsi- 
ble for sexual behavior in birds (Bell and Freeman, 1971), 
AGnRH-I-treated females might not have exhibited suffi- 
cient behavioral cues to elicit sexual behavior from the 
male. As a result, females might have been chased less 
by males, and more time might have been spent feeding, 
resulting in increased weight gain. 
Similarly, low antibody titers and a lack of reduced 
hatchability with the cRCP vaccination indicate that the 
antibody titers generated were not high enough to have 
an effect. Vaccination against cRCP likely will not affect 
breeding behavior because it does not affect the reproduc- 
tive hormones. Seshagiri and Adiga (1987) found that vacci- 
nation against cRCP in bonnet monkeys (Macaca vndiata) 
did not alter estrogen and progesterone levels. 
Management Implications 
Of the 3 contraceptives investigated, 20,25 diazacholest- 
erol gave the most promising results. It was efficacious for 
both sexes and reduced egg production and hatchability. 
Because 20,25 diazacholesterol is effective for 2 2 mo in 
Coturnix quail and is reversible, it is a promising contracep- 
tive for field use. However, additional dose-response work 
will need to be conducted on 20,25 diazacholesterol to 
minimize the risk of birds receiving a toxic dose. Because 
the level of 20,25 diazacholesterol that causes toxicity will 
vary by species, lab tests will need to be conducted to 
establish appropriate dosages. It may be necessary to use 
desmosterol and nonesterified cholesterol as markers be- 
cause many of the species of interest will not breed in a 
laboratory setting. 
An advantage of the AGnRH-I vaccine is that it can 
potentially contracept both sexes. The potential length of 
efficacy of the AGnRH-I vaccine, and its reversibility, make 
it another promising field contraceptive. Although the 
overall results did not show an effect, it is clear from the 
few responders in the male and female treated groups that 
this vaccine has potential to work. Further research should 
be done on finding the best vaccination protocol to max- 
imize antibody titers. This vaccination protocol should also 
be tested with cRCP to determine if the failure of the vaccine 
was due to the vaccine or the vaccination protocol. In order 
to be practical for field use, an oral vaccine or other method 
of delil~ery that does not require capture of birds (such as 
intradermal) will need to be developed. 
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